IL113252A0 - Eph receptors binding ligands - Google Patents
Eph receptors binding ligandsInfo
- Publication number
- IL113252A0 IL113252A0 IL11325295A IL11325295A IL113252A0 IL 113252 A0 IL113252 A0 IL 113252A0 IL 11325295 A IL11325295 A IL 11325295A IL 11325295 A IL11325295 A IL 11325295A IL 113252 A0 IL113252 A0 IL 113252A0
- Authority
- IL
- Israel
- Prior art keywords
- binding ligands
- eph receptors
- receptors binding
- ligands
- novel
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL13564900A IL135649A0 (en) | 1994-04-04 | 2000-04-13 | Biologically active eph family ligand |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US22207594A | 1994-04-04 | 1994-04-04 | |
US22940294A | 1994-04-12 | 1994-04-12 | |
US08/299,567 US5747033A (en) | 1993-10-28 | 1994-09-01 | Method of enhancing the biological activity of Eph family ligands |
US32742394A | 1994-10-21 | 1994-10-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
IL113252A0 true IL113252A0 (en) | 1995-07-31 |
Family
ID=27499262
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL11325295A IL113252A0 (en) | 1994-04-04 | 1995-04-04 | Eph receptors binding ligands |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP0758381B2 (xx) |
JP (1) | JP3686084B2 (xx) |
AT (1) | ATE232901T1 (xx) |
AU (1) | AU691915B2 (xx) |
CA (1) | CA2187167A1 (xx) |
DE (1) | DE69529674T3 (xx) |
ES (1) | ES2192199T5 (xx) |
IL (1) | IL113252A0 (xx) |
WO (1) | WO1995027060A2 (xx) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5824303A (en) * | 1992-11-13 | 1998-10-20 | Amgen Inc. | Eck receptor ligands |
US5624899A (en) * | 1994-07-20 | 1997-04-29 | Genentech Inc. | Method for using Htk ligand |
ATE263781T1 (de) * | 1994-10-27 | 2004-04-15 | Genentech Inc | Neurotrophischer al-1 faktor, einer ligand verwant mit dem eph tyrosine kinase receptor |
US5759775A (en) | 1994-10-27 | 1998-06-02 | Genetech, Inc. | Methods for detecting nucleic acids encoding AL--1 neurotrophic factor |
JPH11515105A (ja) * | 1995-10-13 | 1999-12-21 | マウント・サイナイ・ホスピタル・コーポレイション | 新規リガンド調節経路の活性化方法 |
US6610296B2 (en) | 1995-10-26 | 2003-08-26 | Genentech, Inc. | Methods of enhancing cognitive function using an AL-1 neurotrophic factor immunoadhesin |
US6696557B1 (en) | 1996-04-19 | 2004-02-24 | Genentech, Inc. | AL-2 neurotrophic factor nucleic acid |
US6413730B1 (en) | 1996-07-05 | 2002-07-02 | Mount Sinai Hospital Corporation | Method for identifying compounds that inhibit or enhance activation of a transmembrane ligand for a receptor tyrosine kinase |
US5994112A (en) * | 1996-10-09 | 1999-11-30 | Incyte Pharmaceuticals, Inc. | Human protein tyrosine kinase |
CA2355163A1 (en) * | 1998-12-18 | 2000-06-29 | Mount Sinai Hospital | Three dimensional structure of a sterile alpha motif domain |
DE69924009T2 (de) | 1998-12-23 | 2006-04-13 | Regeneron Pharmaceuticals, Inc. | Methode zur verstärkung der biologischen aktivität von liganden |
EP2789630A1 (en) | 2013-04-09 | 2014-10-15 | EngMab AG | Bispecific antibodies against CD3e and ROR1 |
CA2963692A1 (en) | 2014-10-09 | 2016-04-14 | Engmab Ag | Bispecific antibodies against cd3epsilon and ror1 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5151360A (en) * | 1990-12-31 | 1992-09-29 | Biomembrane Institute | Effect of n,n,n-trimethylsphingosine on protein kinase-c activity, melanoma cell growth in vitro, metastatic potential in vivo and human platelet aggregation |
AU685765B2 (en) * | 1992-11-13 | 1998-01-29 | Amgen, Inc. | (Eck) receptor ligands |
WO1994011384A1 (en) * | 1992-11-13 | 1994-05-26 | Immunex Corporation | Novel cytokine designated elk ligand |
US5516658A (en) * | 1993-08-20 | 1996-05-14 | Immunex Corporation | DNA encoding cytokines that bind the cell surface receptor hek |
-
1995
- 1995-04-04 AT AT95916204T patent/ATE232901T1/de not_active IP Right Cessation
- 1995-04-04 EP EP95916204A patent/EP0758381B2/en not_active Expired - Lifetime
- 1995-04-04 DE DE69529674T patent/DE69529674T3/de not_active Expired - Fee Related
- 1995-04-04 CA CA002187167A patent/CA2187167A1/en not_active Abandoned
- 1995-04-04 AU AU22789/95A patent/AU691915B2/en not_active Ceased
- 1995-04-04 ES ES95916204T patent/ES2192199T5/es not_active Expired - Lifetime
- 1995-04-04 JP JP52594195A patent/JP3686084B2/ja not_active Expired - Fee Related
- 1995-04-04 IL IL11325295A patent/IL113252A0/xx not_active IP Right Cessation
- 1995-04-04 WO PCT/US1995/004208 patent/WO1995027060A2/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
DE69529674T3 (de) | 2007-06-28 |
AU2278995A (en) | 1995-10-23 |
JP3686084B2 (ja) | 2005-08-24 |
WO1995027060A2 (en) | 1995-10-12 |
DE69529674D1 (de) | 2003-03-27 |
WO1995027060A3 (en) | 1995-11-02 |
ES2192199T3 (es) | 2003-10-01 |
EP0758381A1 (en) | 1997-02-19 |
DE69529674T2 (de) | 2003-12-18 |
EP0758381B2 (en) | 2006-11-15 |
EP0758381B1 (en) | 2003-02-19 |
ATE232901T1 (de) | 2003-03-15 |
AU691915B2 (en) | 1998-05-28 |
JPH09511401A (ja) | 1997-11-18 |
CA2187167A1 (en) | 1995-10-12 |
ES2192199T5 (es) | 2007-07-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL113252A0 (en) | Eph receptors binding ligands | |
IL142905A0 (en) | Functional antagonists of hedgehog activity | |
MX9605365A (es) | Fracciones polipeptidicas solubles de la proteina lag-3; procedimiento de produccion; composicion terapeutica y anticuerpos ant-idiotipo. | |
CA2095153A1 (en) | Genetic modification of endothelial cells | |
UA29494C2 (uk) | Гуманізовані антитіла, способи їх продукування, спосіб лікування хвороби крона, спосіб лікування розсіяного склерозу, фармацевтична композиція | |
HK1008400A1 (en) | Genetic modification of endothelial cells | |
BG104149A (en) | Interleukin-18-binding proteins, methods for their preparation and administration | |
TW221675B (xx) | ||
MY104673A (en) | Binding proteins for insulin-like growth factors. | |
CY1107821T1 (el) | Πολυπεπτιδιο παραγοντα viii με ενεργοτητα παραγοντα viii:c | |
IL193886A (en) | Antibodies that bind to ldcam sequences | |
WO2000053761A3 (en) | Human cytokine as ligand of the zalpha receptor and uses thereof | |
AU2001253127A1 (en) | Soluble zalpha11 cytokine receptors | |
BG102817A (en) | Modulators of factor traf asociated with tnf-receptor, their preparation and application | |
ES8504938A1 (es) | Un metodo de producir una proteina interferon inmune humano | |
EP0515516A4 (en) | Totally synthetic affinity reagents | |
WO2002012345A3 (en) | Soluble zcytor 11 cytokine receptors | |
ES8606494A1 (es) | Un metodo de producir un peptido o polipeptido sintetico. | |
PL349158A1 (en) | Method of enhancing the biological activity of ligands | |
DE69712124D1 (de) | Hormones de croissance humaines mutantes et leur utilisation | |
AU7477896A (en) | Biologically active eph family ligands | |
IL127363A0 (en) | IL-1/TNF-alpha-activated kinase and methods of making and using the same | |
CA2236001A1 (en) | Biologically active eph family ligands | |
MXPA02011938A (es) | Adn que codifica para un receptor de histamina de mamifero del subtipo h4. | |
MY134493A (en) | Thrombopoietin peptides, fragments, nucleic acids encoding the same, and method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
MM9K | Patent not in force due to non-payment of renewal fees |